Flovent Discontinuation in 2024 Raises Concerns for Doctors, Patients
Flovent is being discontinued in the new year; insurance coverage of alternatives is uncertain
Nirsevimab Protects Infants Against RSV-Linked Hospitalization
Nirsevimab efficacious for preventing RSV-associated lower respiratory tract infection and very severe RSV-associated LRTI
Nearly Half of U.S. COVID-19 Cases Now Caused by JN.1 Variant
The speed at which the JN.1 variant has spread this month suggests it may spread more easily and be better at evading immune system
Hispanic, Indigenous Americans Undercaptured in National Cancer Database
Representation of Hispanic, American Indian or Alaska Native individuals with breast, colorectal, lung, and prostate cancer improved over time
Private Equity Acquisition of Hospitals May Increase Adverse Events
Medicare beneficiaries admitted to private equity hospitals experienced increase in hospital-acquired conditions
More Than Half of U.S. Medical Interns Experience Sexual Harassment
Variation seen by institution and specialty training
SARS-CoV-2 Rebound Rate Similar With, Without Oral Antivirals
Second study shows similar rates of SARS-CoV-2 RNA shedding and viral rebound for those receiving nirmatrelvir/ritonavir or placebo
Daily Toothbrushing Cuts Hospital-Acquired Pneumonia
Findings particularly strong among patients undergoing invasive mechanical ventilation
Air Pollution Tied to Multimorbidity Status, Severity
Higher exposures to particulate matter and nitrogen dioxide associated with multimorbidity status in dose-dependent manner
Many U.S. Nursing Home Residents Have Not Been Vaccinated for Flu, COVID-19, or RSV...
Second study shows that 42.2 and 18.3 percent of individuals aged 18 years and older reported receiving flu, updated COVID-19 shots
